SCHEMBL29131086

SCHEMBL29131086

NC(=O)OCc1ccc(-c2nc(Cl)ncc2Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.39
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
CDK1 P06493 1/20 0.36
KDR P35968 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CNR1 P21554 1/20 0.34
PDK1 Q15118 9/20 0.34
PDK2 Q15119 2/20 0.34
PDK4 Q16654 2/20 0.34
PDK3 Q15120 1/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29131077 0.77 MAP4K4 (0.45) KDM4EMEN1KMT2APOLBL3MBTL1
SCHEMBL22544661 0.74 BTK (0.43) BTKMEN1KMT2APOLB
SCHEMBL28532598 0.74 LMNA (0.39) MEN1CYP1A2KMT2ANPSR1TDP1
SCHEMBL16446429 0.73 RARA (0.49) KDM4EMEN1CYP1A2CYP3A4KMT2A
SCHEMBL22097892 0.72 CDH1 (0.45) BTKKDM4EMEN1KMT2A
SCHEMBL30437401 0.72 KMT2A (0.50) MEN1CYP1A2KMT2ANPSR1TDP1
SCHEMBL5385077 0.70 MAP2K4 (0.47) BTKKDM4EMEN1KMT2AKDR
SCHEMBL30919628 0.70 KDM4E (0.42) BTKKDM4ECYP1A2CNR1L3MBTL1
SCHEMBL113937 0.70 IDO1 (0.54) MEN1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10691581 0.70 ALDH1A1 (0.51) KDM4EMEN1KMT2ATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088851-A Pyrimidine amine NUAK inhibitor and preparation method and application thereof 特科罗生物科技(成都)有限公司 2023-11-21 CN disclosed